Albany International vs Parker-Hannifin: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Albany International Corporation (AIN)

Q3 202623 Jul – 3 Sep 2026

▲3▼1

Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty

Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.
This is the core positive driver showing strong demand in Albany's growth segment.
Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.
This is a major new event that directly boosts earnings expectations and removes uncertainty.
Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.
This new contract extension secures future revenue and reinforces the positive demand trend.
CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.
This is a new negative event that weighs on the stock by adding uncertainty.

August 202623 Jul – 3 Sep 2026

▲3▼1

Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty

Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.
This is the core positive driver showing strong demand in Albany's growth segment.
Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.
This is a major new event that directly boosts earnings expectations and removes uncertainty.
Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.
This new contract extension secures future revenue and reinforces the positive demand trend.
CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.
This is a new negative event that weighs on the stock by adding uncertainty.

Latest23 Jul – 3 Sep 2026

▲3▼1

Albany's composites growth and strategic review progress offset weak textile demand and CFO uncertainty

Record Engineered Composites revenue and new business wins Albany's Engineered Composites segment hit a record $150.8 million in Q2 2026 revenue, up 16% on ramping LEAP, Boeing, and CH-53K programs. New wins like the Pratt & Whitney GTF contract support long-term growth, pushing the stock up on optimism about future sales.
This is the core positive driver showing strong demand in Albany's growth segment.
Strategic review completed, Utah facility retained, guidance raised Albany finished its review of the Salt Lake City plant and decided to keep it after securing new business, a renegotiated Boeing 787 contract, and better Sikorsky CH-53K terms. It raised Q3 adjusted EPS guidance to $1.40-$1.50 from $0.60-$0.70, signaling improved profitability and cash flow starting 2027.
This is a major new event that directly boosts earnings expectations and removes uncertainty.
Boeing 787 contract extended for composite frames Albany Engineered Composites agreed with Boeing to keep making about 300 unique composite fuselage frames for the 787 Dreamliner, a role held since 2014. This locks in steady demand for its composites segment, supporting revenue visibility and investor confidence.
This new contract extension secures future revenue and reinforces the positive demand trend.
CFO medical leave creates leadership uncertainty Albany's CFO Willard Station is on medical leave, and controller Sean Valashinas is acting CFO. Shares fell 4.82% on the news as investors worry about a gap in financial leadership, though the company moved quickly to fill the role temporarily.
This is a new negative event that weighs on the stock by adding uncertainty.

Parker-Hannifin Corporation (PH)

Q3 202626 Jun – 2 Oct 2026

▲3

Parker-Hannifin Q3: Record Sales, Raised Guidance, Strategic Acquisitions

Record Sales and Earnings Beat Parker-Hannifin reported record quarterly sales of $5.8 billion and adjusted EPS of $9.27, up 21% and beating estimates, showcasing strong operational performance.
This point highlights the core financial results that drove positive investor sentiment.
Raised Guidance and Margin Target Management increased fiscal 2027 EPS guidance and set a new long-term margin target of 30%, leading to an 8–10% stock jump as investors welcomed the optimistic outlook.
This point explains the forward-looking catalyst that directly boosted the stock price.
Strong Orders and Backlog Companywide orders rose 18–19%, with backlog reaching a record $12.8 billion, and aerospace organic sales climbed 13.3%, indicating robust demand across key segments.
This point underscores the demand strength that supports future revenue growth.
Acquisitions Add Growth but Debt and Integration Risks Parker completed Curtis Instruments and Filtration Group acquisitions and agreed to buy CIRCOR's aerospace division, expanding filtration and aerospace exposure, but these deals add debt, integration costs, and execution risk.
This point captures the strategic expansion balanced against potential financial and operational challenges.

September 202615 Aug – 2 Oct 2026

▲4

Parker-Hannifin beats, raises guidance, and expands via acquisitions

Q2 earnings beat and raised FY2027 guidance Parker-Hannifin reported Q2 revenue of $5.76 billion, up 9.8% year over year, beating estimates, with adjusted EPS of $9.27 versus $8.27 expected. Management raised fiscal 2027 EPS guidance above consensus, signaling strong profitability and future earnings power, which supports a higher stock price.
This is the core new financial result that directly boosts investor confidence and earnings expectations.
Aerospace momentum and strong orders Aerospace organic sales jumped 13.3% year over year and orders rose 18%, with fiscal 2027 organic growth guided at 7-10%. This shows robust demand in a high-margin segment, likely driving future revenue and profit growth, pushing the stock up.
It highlights a key growth engine that underpins the bullish outlook and differentiates PH from slower industrial peers.
Filtration Group acquisition completed Parker-Hannifin completed the acquisition of Filtration Group, expected to add about $1.8 billion in sales in fiscal 2027 and provide cost synergies. This expands the company's filtration footprint and aftermarket presence, supporting earnings growth, though it adds debt and integration costs.
It is a major strategic move that increases scale and future sales, directly affecting the growth story.
Pending CIRCOR aerospace acquisition Parker-Hannifin agreed to buy CIRCOR's aerospace division for $2.6 billion, adding actuation and landing gear systems. The deal is pending but expected to close, strengthening the aerospace portfolio and long-term growth, though it will add debt and integration costs.
It is a significant acquisition that expands aerospace capabilities and is part of the broader M&A strategy driving future growth.

Latest15 Aug – 2 Oct 2026

▲4

Parker-Hannifin beats, raises guidance, and expands via acquisitions

Q2 earnings beat and raised FY2027 guidance Parker-Hannifin reported Q2 revenue of $5.76 billion, up 9.8% year over year, beating estimates, with adjusted EPS of $9.27 versus $8.27 expected. Management raised fiscal 2027 EPS guidance above consensus, signaling strong profitability and future earnings power, which supports a higher stock price.
This is the core new financial result that directly boosts investor confidence and earnings expectations.
Aerospace momentum and strong orders Aerospace organic sales jumped 13.3% year over year and orders rose 18%, with fiscal 2027 organic growth guided at 7-10%. This shows robust demand in a high-margin segment, likely driving future revenue and profit growth, pushing the stock up.
It highlights a key growth engine that underpins the bullish outlook and differentiates PH from slower industrial peers.
Filtration Group acquisition completed Parker-Hannifin completed the acquisition of Filtration Group, expected to add about $1.8 billion in sales in fiscal 2027 and provide cost synergies. This expands the company's filtration footprint and aftermarket presence, supporting earnings growth, though it adds debt and integration costs.
It is a major strategic move that increases scale and future sales, directly affecting the growth story.
Pending CIRCOR aerospace acquisition Parker-Hannifin agreed to buy CIRCOR's aerospace division for $2.6 billion, adding actuation and landing gear systems. The deal is pending but expected to close, strengthening the aerospace portfolio and long-term growth, though it will add debt and integration costs.
It is a significant acquisition that expands aerospace capabilities and is part of the broader M&A strategy driving future growth.

July 202626 Jun – 7 Aug 2026

▲3

Parker-Hannifin Hits Records on Aerospace Demand and Raised Guidance

Record quarter and bullish 2027 outlook Parker reported record quarterly sales of $5.8 billion and adjusted EPS of $9.27, up 21%. It guided fiscal 2027 EPS to $34.25-$35.25 and raised its long-term margin target to 30%, fueling an 8-10% stock jump.
The earnings beat and raised guidance are the main new events that moved the stock sharply.
Orders jump 19%, backlog at record Companywide orders rose 19% and total backlog hit a record $12.8 billion, signaling customers are buying more and future revenue is locked in. This strong demand visibility supports higher earnings and a higher stock price.
Order growth and record backlog are fresh evidence of durable demand that directly boosts investor confidence.
Acquisitions expand filtration and aerospace Parker completed the Curtis Instruments deal and agreed to buy Filtration Group and CIRCOR's aerospace business. These add new products and markets, which should grow sales and profits over time, though they also add integration risk.
Acquisitions are a major strategic driver that can lift long-term growth and justify a higher valuation.

26 Jun – 7 Aug 2026

▲3

Parker-Hannifin Hits Records on Aerospace Demand and Raised Guidance

Record quarter and bullish 2027 outlook Parker reported record quarterly sales of $5.8 billion and adjusted EPS of $9.27, up 21%. It guided fiscal 2027 EPS to $34.25-$35.25 and raised its long-term margin target to 30%, fueling an 8-10% stock jump.
The earnings beat and raised guidance are the main new events that moved the stock sharply.
Orders jump 19%, backlog at record Companywide orders rose 19% and total backlog hit a record $12.8 billion, signaling customers are buying more and future revenue is locked in. This strong demand visibility supports higher earnings and a higher stock price.
Order growth and record backlog are fresh evidence of durable demand that directly boosts investor confidence.
Acquisitions expand filtration and aerospace Parker completed the Curtis Instruments deal and agreed to buy Filtration Group and CIRCOR's aerospace business. These add new products and markets, which should grow sales and profits over time, though they also add integration risk.
Acquisitions are a major strategic driver that can lift long-term growth and justify a higher valuation.